X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45271) 45271
Newspaper Article (15387) 15387
Newsletter (10281) 10281
Publication (4107) 4107
Trade Publication Article (913) 913
Magazine Article (504) 504
Book Review (436) 436
Web Resource (221) 221
Book Chapter (190) 190
Dissertation (102) 102
Transcript (74) 74
Conference Proceeding (70) 70
Government Document (67) 67
Book / eBook (17) 17
Report (14) 14
Data Set (7) 7
Reference (6) 6
Journal / eJournal (2) 2
Presentation (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ovarian cancer (57860) 57860
humans (28061) 28061
cancer (27300) 27300
oncology (24036) 24036
female (22735) 22735
index medicus (21796) 21796
chemotherapy (16828) 16828
research (16742) 16742
care and treatment (12665) 12665
ovarian-cancer (11854) 11854
cancer therapies (10331) 10331
middle aged (10312) 10312
health aspects (8836) 8836
tumors (8789) 8789
oncology, experimental (8756) 8756
adult (8434) 8434
aged (8176) 8176
breast cancer (8016) 8016
ovarian neoplasms - pathology (7192) 7192
metastasis (6910) 6910
genetic aspects (6662) 6662
animals (6523) 6523
ovarian neoplasms - drug therapy (6481) 6481
carcinoma (6366) 6366
apoptosis (6228) 6228
analysis (6082) 6082
prognosis (6028) 6028
cell line, tumor (5978) 5978
obstetrics & gynecology (5625) 5625
expression (5519) 5519
drug therapy (5447) 5447
women (5377) 5377
medical research (5176) 5176
womens health (5129) 5129
clinical trials (5016) 5016
proteins (4934) 4934
breast-cancer (4734) 4734
gene expression (4672) 4672
reports (4671) 4671
mutation (4235) 4235
survival (4228) 4228
surgery (4146) 4146
male (4065) 4065
patients (4045) 4045
development and progression (4041) 4041
mice (4009) 4009
studies (3976) 3976
cisplatin (3953) 3953
ovarian neoplasms - genetics (3772) 3772
medical prognosis (3563) 3563
antineoplastic agents (3531) 3531
risk factors (3467) 3467
antimitotic agents (3382) 3382
pharmaceutical industry (3280) 3280
paclitaxel (3256) 3256
ovarian neoplasms - metabolism (3171) 3171
neoplasm staging (3110) 3110
medicine (3068) 3068
aged, 80 and over (3058) 3058
immunotherapy (3041) 3041
diagnosis (3027) 3027
therapy (3012) 3012
article (2911) 2911
treatment outcome (2894) 2894
cell biology (2847) 2847
drugs (2844) 2844
kinases (2792) 2792
hematology, oncology and palliative medicine (2732) 2732
antineoplastic combined chemotherapy protocols - therapeutic use (2694) 2694
pharmacology & pharmacy (2600) 2600
medicine & public health (2546) 2546
lung cancer (2516) 2516
drug resistance (2512) 2512
genes (2500) 2500
research article (2442) 2442
antineoplastic agents - therapeutic use (2424) 2424
biomarkers (2418) 2418
obstetrics and gynecology (2400) 2400
biochemistry & molecular biology (2344) 2344
cells (2318) 2318
antineoplastic agents - pharmacology (2300) 2300
cell cycle (2287) 2287
gynecology (2271) 2271
immunohistochemistry (2268) 2268
medicine, research & experimental (2268) 2268
ovarian carcinoma (2241) 2241
retrospective studies (2216) 2216
cancer patients (2133) 2133
ovarian neoplasms - therapy (2104) 2104
universities and colleges (2069) 2069
health risk assessment (2021) 2021
stem cells (2021) 2021
gene expression regulation, neoplastic (2012) 2012
deoxyribonucleic acid--dna (2007) 2007
ovarian neoplasms - mortality (1969) 1969
cell growth (1966) 1966
cell proliferation (1955) 1955
growth (1915) 1915
endometrial cancer (1904) 1904
physiological aspects (1896) 1896
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (72271) 72271
German (265) 265
French (178) 178
Polish (89) 89
Korean (58) 58
Japanese (36) 36
Spanish (33) 33
Russian (31) 31
Chinese (27) 27
Italian (9) 9
Czech (7) 7
Hungarian (6) 6
Turkish (4) 4
Persian (3) 3
Slovenian (3) 3
Arabic (2) 2
Slovak (2) 2
Catalan (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 305 - 312
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1324 - 1334
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 22, pp. 2154 - 2164
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 223 - 230
Abstract Objectives Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval debulking surgery (IDS) is the main objective of... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Neoadjuvant chemotherapy | Number of cycles | Interval surgery | Prognosis | Epithelial ovarian cancer | Number of cycles Prognosis | SURVIVAL | TRIALS | CYTOREDUCTIVE SURGERY | METAANALYSIS | SENSITIVITY | RESIDUAL DISEASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | ADVANCED-STAGE OVARIAN | RESISTANCE | PRIMARY DEBULKING SURGERY | CARCINOMA | Adenocarcinoma - pathology | Adenocarcinoma, Mucinous - pathology | Carcinosarcoma - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Cytoreduction Surgical Procedures | Young Adult | Carcinoma, Endometrioid - surgery | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Adenocarcinoma, Mucinous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Neoplasms, Glandular and Epithelial - pathology | Reoperation | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma - drug therapy | Cystadenocarcinoma, Serous - surgery | Neoplasms, Glandular and Epithelial - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Adenocarcinoma, Clear Cell - pathology | Aged | Carcinosarcoma - drug therapy | Platinum Compounds - administration & dosage | Carcinoma, Endometrioid - pathology | Adenocarcinoma - surgery | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Ovarian Neoplasms - surgery | Cancer patients | Care and treatment | Surgery | Adjuvant treatment | Ovarian cancer | Cancer | Life Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 14, pp. 1324 - 1334
Journal Article